Published Date: 02 Mar 2023
High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.
Read Full News1.
Survivors of childhood brain cancer are more likely to be held back in school
2.
Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts
3.
Patients value communication skills from cancer surgeons across six key areas, according to research
4.
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
5.
Young adults who are obese are at risk for 17 different types of cancer in the future.
1.
A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing
2.
Polyposis Syndrome: Causes, Symptoms, and Treatment Options
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
The Science Behind Thrombolytic Drugs and Their Benefits
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
Navigating the Complexities of Ph Negative ALL - Part XIII
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation